A federal appellate court ordered the U.S. Drug Enforcement Administration to respond within a month to a lawsuit claiming that it has unlawfully failed to act on medical cannabis research applications since 2016. Such research is critical to assessing public health benefits, which, in turn, could create additional industry opportunities. The order by the U.S.
DEA ordered to explain delay in acting on medical marijuana research apps is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
[Read More ...]
George Scorsis Liberty Health Sciences
Originally posted on DEA ordered to explain delay in acting on medical marijuana research apps via George Scorsis Medical Marijuana News
No comments:
Post a Comment